Roche A, Lasser P, de Baère T, Elias D
Service de radiologie interventionnelle, institut Gustave-Roussy, Villejuif, France.
Chirurgie. 1998 Feb;123(1):67-72; discussion 73. doi: 10.1016/s0001-4001(98)80041-x.
The aim of the preoperative portal embolization is a redistribution of the portal venous blood flow in an attempt to induce hypertrophy of the future remnant liver in order to perform a curative liver resection.
Preoperative portal embolization was performed in a group of 43 patients. The volumetric ratio (future remnant liver/total liver-tumor) was 20%. Liver metastases were present in 40 patients and primary liver tumor in three. Twenty-four patients had received chemotherapy prior to the preoperative portal embolization. Required operative procedures were right hepatectomy (n = 15), right hepatectomy extended to the segment IV (n = 24) or atypical resection (n = 4). Preoperative portal embolization was performed under percutaneous transhepatic approach with a Blue Histoacryl and Lipiodol Ultra Fluide mixture. Liver volumetric measurements were obtained with 3D color encoded computed tomography, before portal embolization and before surgery.
Hypertrophy of the future remnant liver was 83 +/- 58% after a mean 32-day interval between portal embolization and surgery. The tolerance of portal embolization was excellent. Thirty-six hepatectomies were performed as initially planned; seven were cancelled for emergence of metastases (distant in six patients and intrahepatic in one).
Pre-operative portal embolization is a safe and effective procedure which increases the possibilities of curative resection in the liver tumors.
术前门静脉栓塞的目的是重新分配门静脉血流,试图诱导未来残余肝脏肥大,以便进行根治性肝切除术。
对43例患者进行了术前门静脉栓塞。体积比(未来残余肝脏/全肝-肿瘤)为20%。40例患者存在肝转移,3例为原发性肝癌。24例患者在术前门静脉栓塞前接受过化疗。所需的手术方式为右肝切除术(n = 15)、扩展至IV段的右肝切除术(n = 24)或非典型切除术(n = 4)。术前门静脉栓塞采用经皮经肝途径,使用蓝色组织黏合剂和超液态碘油混合物进行。在门静脉栓塞前和手术前,通过三维彩色编码计算机断层扫描获得肝脏体积测量值。
门静脉栓塞与手术之间平均间隔32天后,未来残余肝脏的肥大率为83±58%。门静脉栓塞的耐受性良好。36例肝切除术按原计划进行;7例因出现转移(6例为远处转移,1例为肝内转移)而取消。
术前门静脉栓塞是一种安全有效的手术,可增加肝肿瘤根治性切除的可能性。